INITIATING PATIENTS ON GLP-1/COMBINED GLP-1 AND GIP AGONISTS: A QUALITY IMPROVEMENT PROJECT
Therapeutic Area: Diabetes Background: Both glucagon-like-peptide-1 (GLP-1) and combined GLP-1/glucose-dependent insulinotropic polypeptide (GIP) agonist medications have shown efficacy on weight loss, diabetes mellitus, and some with cardiovascular mortality benefits as seen with Semaglutide in the...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2024-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |